-
公开(公告)号:KR101775440B1
公开(公告)日:2017-09-06
申请号:KR1020150141171
申请日:2015-10-07
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07D421/06 , C07D345/00 , C07D209/56 , A61K31/095 , A61K31/403 , A61K39/395 , A61K47/48
Abstract: 본원은신규벤조셀레노펜계화합물과이의제조방법및 벤조셀레노펜계화합물을포함하는항체-약물결합체(antibody-drug conjugate; ADC)에관한것이다.
-
公开(公告)号:KR1020140143345A
公开(公告)日:2014-12-16
申请号:KR1020140150420
申请日:2014-10-31
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07C391/02 , C07D317/46
Abstract: 본원은, 셀레닐-치환된 방향족 알데하이드(selenyl-substituted aromatic aldehyde)계 화합물의 신규한 제조 방법에 관한 것으로서, 구체적으로, 셀레놀레이트 친핵체(selenolate nucleophile)를 형성하여 방향족 알데하이드계 출발물질을 친핵성 치환시키는 것을 포함하는, 셀레닐-치환된 방향족 알데하이드계 화합물의 신규한 제조 방법에 관한 것이다.
Abstract translation: 本发明涉及一种制备烯酰基取代的芳族醛基化合物的新方法。 更具体地,该方法包括亲核取代基于芳族醛的原料的步骤。
-
13.
公开(公告)号:KR1020140123470A
公开(公告)日:2014-10-22
申请号:KR1020140133014
申请日:2014-10-02
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07D421/06 , C07D421/14 , A61K31/555 , A61P35/00
Abstract: 셀레노펜-접합 방향족(selenophene-fused aromatic) 화합물을 포함하는 항암제에 관한 것이다.
Abstract translation: 本发明涉及含硒硒稠合芳族化合物的抗癌剂。 本发明可以更容易且经济地制备具有各种取代基的硒酚稠合芳香族化合物,并且在制备硒代苯并稠合芳香族化合物时,作为原料的芳香族起始原料的种类多样化, 稠合芳香族化合物。
-
公开(公告)号:KR1020130120635A
公开(公告)日:2013-11-05
申请号:KR1020120043678
申请日:2012-04-26
Applicant: 울산대학교 산학협력단 , 세종대학교산학협력단
CPC classification number: A01N43/38 , A01N25/12 , A23L3/34635 , A61K31/404 , A61L2420/06
Abstract: The present invention relates to an antimicrobial composition which contains a specific compound or salt thereof as an active component. The specific compound or salt thereof is capable of being coated on antimicrobial drugs, health food, and artificial implants including central venous catheters, artificial joints, and artificial valves for preventing the generation of a bio film on the artificial implants and directly controlling the generation of bacterial by having antimicrobial activity. The antimicrobial composition is capable of being useful as a coating composition for preventing the infection on the artificial implants.
Abstract translation: 本发明涉及含有作为活性成分的特定化合物或其盐的抗微生物组合物。 特定的化合物或其盐能够被涂覆在抗菌药物,保健食品和包括中心静脉导管,人造关节和人造瓣膜的人造植入物上,用于防止在人造植入物上产生生物膜并直接控制 细菌具有抗菌活性。 抗微生物组合物能够用作防止人造植入物感染的涂料组合物。
-
15.
公开(公告)号:KR1020130064018A
公开(公告)日:2013-06-17
申请号:KR1020120139440
申请日:2012-12-04
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07D421/06 , C07D421/14 , A61K31/555 , A61P35/00
Abstract: PURPOSE: An anticancer agent containing a selenophene-conjugated aromatic compound is provided to easily and cheaply obtain the selenophene-conjugated aromatic compound. CONSTITUTION: A selenophene-conjugated aromatic compound is denoted by chemical formula 1, 2, and 3. An anticancer composition contains the selenophene-conjugated aromatic compound. A method for preparing the selenophene-conjugated aromatic compound comprises a step of reacting an MCBI(7-methoxy-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one) compound of chemical formula 1a and a selenium-containing aromatic compound of chemical formula 1b.
Abstract translation: 目的:提供含有硒吩酚共轭芳香族化合物的抗癌剂,容易且廉价地得到硒吩衍生的芳香族化合物。 构成:硒酚共轭芳族化合物由化学式1,2和3表示。抗癌组合物含有硒吩酚共轭芳族化合物。 制备该硒代苯并咪唑化合物的方法包括使化学式1a的MCBI(7-甲氧基-1,2,9,9a-四氢环丙[c]苯并[e]吲哚-4-酮)化合物与 化学式1b的含硒芳香族化合物。
-
公开(公告)号:KR101050273B1
公开(公告)日:2011-07-19
申请号:KR1020080116406
申请日:2008-11-21
Applicant: 세종대학교산학협력단
Abstract: 본 발명은 하기 의 살렌 전이금속 착화합물을 개시한다:
상기 식에서,
R
1 , R
2 , R
3 , R
4 , R
5 , R
6 , R
7 , R
8 , R
9 , R
10 , R
11 , R
12 , Ar
1 , Ar
2 , A , M, X, m 및 n은 발명의 상세한 설명을 참조한다.
살렌Abstract translation: 本发明涉及到<公开的沙仑 - 过渡金属配合物;式1&GT:
-
公开(公告)号:KR1020170038770A
公开(公告)日:2017-04-07
申请号:KR1020170038519
申请日:2017-03-27
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07C391/02 , C07D317/46
Abstract: 본원은, 셀레닐-치환된방향족알데하이드(selenyl-substituted aromatic aldehyde)계화합물의신규한제조방법에관한것으로서, 구체적으로, 셀레놀레이트친핵체(selenolate nucleophile)를형성하여방향족알데하이드계출발물질을친핵성치환시키는것을포함하는, 셀레닐-치환된방향족알데하이드계화합물의신규한제조방법에관한것이다.
Abstract translation: 本发明涉及一种制备硒代 - 取代的芳香醛基化合物的新方法,更具体地涉及一种制备硒代亲核试剂以形成芳香醛 - 取代的芳香醛基化合物。
-
公开(公告)号:KR1020130069463A
公开(公告)日:2013-06-26
申请号:KR1020120145699
申请日:2012-12-13
Applicant: 세종대학교산학협력단 , 서울대학교산학협력단
IPC: C07D493/22 , A61K31/335 , A61P35/00
Abstract: PURPOSE: A pectenotoxin-2 derivative with various useful physical properties is provided to be used as an anticancer agent or a precursor thereof. CONSTITUTION: A pectenotoxin-2 derivative is denoted by chemical formula 1. An anticancer composition contains the derivative and removes cancer cells in human body. The cancer cells include cancer cells of lung, colon, central nervous system, skin, ovary, kidney, breast, or stomach.
Abstract translation: 目的:提供具有各种有用物理性质的果胶毒素-2衍生物作为抗癌剂或其前体。 构成:化学式1表示果胶毒素-2衍生物。抗癌组合物含有衍生物并去除人体中的癌细胞。 癌细胞包括肺,结肠,中枢神经系统,皮肤,卵巢,肾,乳腺或胃的癌细胞。
-
公开(公告)号:KR1020120125573A
公开(公告)日:2012-11-15
申请号:KR1020110042766
申请日:2011-05-06
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07C391/02 , C07D317/46 , C07D211/80 , C07D491/06
Abstract: PURPOSE: A manufacturing method of selenyl-substituted aromatic aldehyde-based compound is provided to obtain selenyl-sbustituted aromatic aldehyde-based compound with high yield while minimizing generation of byproduct of a reaction. CONSTITUTION: A manufacturing method of selenyl-substituted aromatic aldehyde-based compound indicated in chemical formula 4 comprises: a step of preparing a reaction mixture comprising diselenide compound represented by A-Se-Se-A, solvent and a reducing agent; and a step of adding and reacting aromatic aldehyde-based starting material and base into the reaction mixture. The equivalent ratio of the diselenide compound and the reducing agent in the reaction mixture is 1:1/3-3.
Abstract translation: 目的:提供烯丙基取代的芳族醛基化合物的制备方法,以最大限度地产生反应副产物的产率,以高产率获得烯丙基取代的芳族醛基化合物。 构成:化学式4中所示的苯乙烯基取代的芳族醛基化合物的制造方法包括:制备包含由A-Se-Se-A表示的二硒化合物,溶剂和还原剂的反应混合物的步骤; 和将芳族醛类原料和碱加入反应混合物中的步骤。 反应混合物中二硒化合物和还原剂的当量比为1:1 / 3-3。
-
公开(公告)号:KR1020170041562A
公开(公告)日:2017-04-17
申请号:KR1020150141171
申请日:2015-10-07
Applicant: 세종대학교산학협력단 , 사회복지법인 삼성생명공익재단
IPC: C07D421/06 , C07D345/00 , C07D209/56 , A61K31/095 , A61K31/403 , A61K39/395 , A61K47/48
Abstract: 본원은신규벤조셀레노펜계화합물과이의제조방법및 벤조셀레노펜계화합물을포함하는항체-약물결합체(antibody-drug conjugate; ADC)에관한것이다.
Abstract translation: 本发明涉及新的苯并硒吩化合物,其制备方法以及包含苯并硒酚化合物的抗体 - 药物偶联物(ADC)。
-
-
-
-
-
-
-
-
-